The Department of Justice has added another set of kickback allegations to its lawsuit against Novartis. In April, the feds accused the Swiss drugmaker of using pharmacy kickbacks to increase sales of its transplant drug Myfortic. Now, the alleged pharmacy kickbacks involve a different drug—the iron chelation therapy Exjade.
Read more: News - FiercePharma http://www.fiercepharma.com/news#ixzz2pvs1cra5
Subscribe at FiercePharma
No comments:
Post a Comment